TD Private Client Wealth LLC Makes New $148,000 Investment in Astera Labs, Inc. (NASDAQ:ALAB)

TD Private Client Wealth LLC acquired a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 1,117 shares of the company’s stock, valued at approximately $148,000.

Other hedge funds have also recently made changes to their positions in the company. Tidal Investments LLC lifted its holdings in Astera Labs by 81.8% in the 3rd quarter. Tidal Investments LLC now owns 45,298 shares of the company’s stock worth $2,373,000 after purchasing an additional 20,388 shares in the last quarter. Proficio Capital Partners LLC lifted its holdings in shares of Astera Labs by 1.8% in the fourth quarter. Proficio Capital Partners LLC now owns 21,626 shares of the company’s stock worth $2,864,000 after buying an additional 390 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Astera Labs during the third quarter worth $530,000. Maverick Capital Ltd. grew its stake in Astera Labs by 16.0% during the third quarter. Maverick Capital Ltd. now owns 1,156,230 shares of the company’s stock valued at $60,575,000 after acquiring an additional 159,480 shares in the last quarter. Finally, State Street Corp increased its holdings in Astera Labs by 173.1% in the 3rd quarter. State Street Corp now owns 698,467 shares of the company’s stock valued at $36,593,000 after acquiring an additional 442,698 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $72.19 on Wednesday. The firm has a market capitalization of $11.71 billion and a PE ratio of -41.73. The business has a 50 day simple moving average of $89.05 and a two-hundred day simple moving average of $90.03. Astera Labs, Inc. has a 1 year low of $36.22 and a 1 year high of $147.39.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Monday, February 10th. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.16). Astera Labs had a negative net margin of 21.05% and a negative return on equity of 10.40%. Equities research analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have commented on the stock. Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $120.00 price objective for the company in a report on Tuesday, January 28th. Needham & Company LLC restated a “buy” rating and set a $140.00 price target on shares of Astera Labs in a report on Tuesday, February 11th. Raymond James initiated coverage on Astera Labs in a research note on Friday, March 14th. They issued an “outperform” rating and a $82.00 price objective on the stock. Northland Capmk raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 28th. Finally, Barclays upped their price target on shares of Astera Labs from $87.00 to $135.00 and gave the company an “overweight” rating in a research note on Friday, January 17th. One research analyst has rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Astera Labs has a consensus rating of “Buy” and a consensus price target of $112.77.

Insider Buying and Selling

In other Astera Labs news, CFO Michael Truett Tate sold 125,800 shares of the firm’s stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $82.53, for a total transaction of $10,382,274.00. Following the transaction, the chief financial officer now directly owns 244,242 shares in the company, valued at $20,157,292.26. This trade represents a 34.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, General Counsel Philip Mazzara sold 50,000 shares of the company’s stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $87.46, for a total value of $4,373,000.00. Following the completion of the sale, the general counsel now owns 191,209 shares of the company’s stock, valued at $16,723,139.14. This represents a 20.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 570,990 shares of company stock valued at $50,242,702 in the last 90 days.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.